Delivery Order SPE2DB25D7067-SPE2DB25FSVXZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,694.97 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count unit) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,052.23 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count packaging) under a firm fixed price arrangement. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 26, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,794.31 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract. This non-set-aside award was executed on August 10, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) under a firm fixed-price contract valued at $1,690.56. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen will fulfill this pharmaceutical delivery from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $7,451.42 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,334.85 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,489.23 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) under a firm fixed price arrangement. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by August 5, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,793.28 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, awarded without set-aside designation on August 18, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract valued at $1,076.10. This non-set-aside award is part of a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as the primary global pharmaceutical support mechanism for...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVXZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,031.28 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a firm fixed price structure. This non-set-aside award was competitively procured and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a critical vendor in the federal medical supply chain, AmerisourceBergen Drug Corp supplies pharmaceuticals and medical products across multiple therapeutic domains to support military and veteran healthcare systems. The Mesalamine delivery represents a routine pharmaceutical procurement from the company's extensive portfolio of brand-name and generic medications, which serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its established IDC vehicle, positions it as a key supplier for DLA's medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 9/11/25 |